As of June 6, 2025, Focus Impact BH3 Acquisition Company was acquired by XCF Global Capital, Inc., in a reverse merger transaction. Focus Impact BH3 Acquisition Company does not have significant ...
Structure-based drug design is the design and optimization of a chemical structure with the goal of identifying a compound suitable for clinical testing — a drug candidate. It is based on knowledge of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback